{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:12:00Z","timestamp":1793506320056,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This article contains highlights of \u201cGuidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients: Recommendations of the CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation,\u201d which was published in the Morbidity and Mortality Weekly Report. There are sections on the prevention of bacterial, viral, fungal, protozoal, and helminth infections and on hospital infection control, strategies for safe living following transplantation, immunizations, and hematopoietic stem cell safety. The guidelines are evidence-based, and prevention strategies are rated by both the strength of the recommendation and the quality of evidence that supports it. Recommendations are given for preventing cytomegalovirus disease with prophylactic or preemptive gancyclovir, herpes simplex virus disease with prophylactic acyclovir, candidiasis with fluconazole, and Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole. Hopefully, following the recommendations made in the guidelines will reduce morbidity and mortality from opportunistic infections in hematopoietic stem cell transplant recipients.<\/jats:p>","DOI":"10.1086\/321805","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T14:30:14Z","timestamp":1027693814000},"page":"139-144","source":"Crossref","is-referenced-by-count":561,"title":["Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients"],"prefix":"10.1093","volume":"33","author":[{"given":"Clare A.","family":"Dykewicz","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention, National Center for Infectious Diseases, Division of AIDS, STD, and TB Laboratory Research, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,7,15]]},"reference":[{"issue":"RR-10","key":"2020110410211231000_R1","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-8","key":"2020110410211231000_R2","first-page":"1","article-title":"USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-12","key":"2020110410211231000_R3","first-page":"1","article-title":"1997 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-10","key":"2020110410211231000_R4","first-page":"1","article-title":"1999 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020110410211231000_R5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinids\/18.3.421","article-title":"Purpose of quality standards for infectious diseases","volume":"18","author":"Gross","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2020110410211231000_R6","first-page":"167","article-title":"The use of peripheral stem cell support of high-dose chemotherapy","volume-title":"Important advances in oncology 1993","author":"Kessinger","year":"1993"},{"key":"2020110410211231000_R7","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood.V86.9.3598.bloodjournal8693598","article-title":"A comparison of filtered leukocyte reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplantation","volume":"86","author":"Bowden","year":"1995","journal-title":"Blood"},{"key":"2020110410211231000_R8","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063","article-title":"Cytomegalovirus pp65 antigenemia guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double blind study","volume":"88","author":"Boeckh","year":"1996","journal-title":"Blood"},{"key":"2020110410211231000_R9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/infdis\/174.5.907","article-title":"Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation","volume":"174","author":"Boeckh","year":"1996","journal-title":"J Infect Dis"},{"key":"2020110410211231000_R10","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood.V86.7.2815.2815","article-title":"Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effect of antiviral therapy after bone marrow transplantation","volume":"86","author":"Einsele","year":"1995","journal-title":"Blood"},{"key":"2020110410211231000_R11","first-page":"361","article-title":"Human cytomegalovirus","volume-title":"Laboratory diagnosis of viral infections","author":"Mendez","year":"1999","edition":"3d ed."},{"key":"2020110410211231000_R12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199112053252303","article-title":"Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplant","volume":"325","author":"Goodrich","year":"1991","journal-title":"N Engl J Med"},{"key":"2020110410211231000_R13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJM199104113241501","article-title":"A randomized controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants","volume":"324","author":"Schmidt","year":"1991","journal-title":"N Engl J Med"},{"key":"2020110410211231000_R14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-118-3-199302010-00003","article-title":"Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant","volume":"118","author":"Goodrich","year":"1993","journal-title":"Ann Intern Med"},{"key":"2020110410211231000_R15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1056\/NEJM198107093050202","article-title":"Acyclovir prophylaxis of herpes simplex infections","volume":"305","author":"Saral","year":"1981","journal-title":"N Engl J Med"},{"key":"2020110410211231000_R16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(83)92248-1","article-title":"Prophylaxis of herpes infections after bone marrow transplantation by oral acyclovir","volume":"2","author":"Gluckman","year":"1983","journal-title":"Lancet"},{"key":"2020110410211231000_R17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-96-3-265","article-title":"Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation","volume":"96","author":"Wade","year":"1982","journal-title":"Ann Intern Med"},{"key":"2020110410211231000_R18","doi-asserted-by":"crossref","first-page":"823","DOI":"10.7326\/0003-4819-100-6-823","article-title":"Oral acyclovir for prevention of herpes simplex reactivation after marrow transplantation","volume":"100","author":"Wade","year":"1984","journal-title":"Ann Intern Med"},{"key":"2020110410211231000_R19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/clinids\/14.1.38","article-title":"Hepatitis due to herpes simplex virus in marrow-transplant recipients","volume":"14","author":"Johnson","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2020110410211231000_R20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"2020110410211231000_R21","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole for fungal infections after marrow transplant: a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"2020110410211231000_R22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/infdis\/153.3.634","article-title":"Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction","volume":"153","author":"Opal","year":"1986","journal-title":"J Infect Dis"},{"key":"2020110410211231000_R23","first-page":"267","article-title":"Pneumocystis carinii pneumonitis following bone marrow transplantation","volume":"10","author":"Tuan","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"2020110410211231000_R24","first-page":"977","article-title":"Low CD4 count in a patient with P. carinii pneumonia after autologous bone marrow transplantation","volume":"15","author":"Castagnola","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"2020110410211231000_R25","first-page":"1211","article-title":"Design and maintenance of hospital ventilation systems and the prevention of airborne nosocomial infections","volume-title":"Hospital epidemiology and infection control","author":"Streifel","year":"1999"},{"key":"2020110410211231000_R26","first-page":"305","article-title":"Parameters for ventilation controlled environments in hospitals","volume-title":"Design, construction and operation of healthy buildings. Solutions to global and regional concerns","author":"Streifel","year":"1998"},{"key":"2020110410211231000_R27","first-page":"1191","article-title":"Guidelines for prevention of nosocomial pneumonia","volume":"39","author":"Centers for Disease Control and Prevention","year":"1994","journal-title":"Respiratory Care"},{"key":"2020110410211231000_R28","first-page":"58","volume-title":"Guidelines for design and construction of hospital and medical facilities","author":"The American Institute of Architects Academy of Architecture for Health, with assistance from the US Department of Health and Human Services","year":"1996"},{"key":"2020110410211231000_R29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0002-9343(84)90243-2","article-title":"Extrinsic risk factors for pneumonia in the patient at high risk of infection","volume":"76","author":"Rhame","year":"1984","journal-title":"Am J Med"},{"issue":"34","key":"2020110410211231000_R30","first-page":"737","article-title":"Outbreaks of Salmonella serotype enteritidis infection associated with consumption of raw shell eggs\u2014United States, 1994\u20131995","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"29","key":"2020110410211231000_R31","first-page":"621","article-title":"Vibrio vulnificus infections associated with eating raw oysters\u2014Los Angeles, 1996","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"03","key":"2020110410211231000_R32","first-page":"48","article-title":"Outbreak of Vibrio parahaemolyticus infection associated with eating raw oysters and clams harvested from Long Island Sound\u2014Connecticut, New Jersey, and New York, 1998","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"47","key":"2020110410211231000_R33","first-page":"1109","article-title":"Viral gastroenteritis associated with eating oysters\u2014Louisiana, December 1996-January 1997","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020110410211231000_R34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3201\/eid0505.990513","article-title":"Cryptosporidium parvum in oysters from commercial harvesting sites in Chesapeake Bay","volume":"5","author":"Fayer","year":"1999","journal-title":"Emerg Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/33\/2\/139\/34125741\/33-2-139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/33\/2\/139\/34125741\/33-2-139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T10:26:48Z","timestamp":1604485608000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/33\/2\/139\/323987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,15]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,7,15]]},"published-print":{"date-parts":[[2001,7,15]]}},"URL":"https:\/\/doi.org\/10.1086\/321805","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,7,15]]},"published":{"date-parts":[[2001,7,15]]}}}